Calculating pH-solubility profile and pHmax for monoprotic salts of poorly water-soluble weak bases

被引:0
|
作者
Meng, Fan [1 ]
Ibrahim, Fady [1 ]
机构
[1] Sanofi US, CMC Formulat, Synthet Platform, 350 Water St, Cambridge, MA 02141 USA
关键词
Pharmaceutical Salt; pH-solubility; pHmax; Salt disproportionation; Solubility prediction; PHARMACEUTICAL SALTS; DEPENDENT SOLUBILITY; CHEMICAL-STABILITY; DRUG; DISPROPORTIONATION; DISSOLUTION; SELECTION; FORMS; COUNTERION; ACIDS;
D O I
10.1016/j.ijpharm.2025.125338
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmaceutical salts are a commonly used strategy to improve the bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs). The selected salt form is expected to have high solubility to obtain optimal supersaturation and sufficient physical stability for adequate shelf life. In this paper, we aim to develop equations to describe critical parameters of salts, including pH-solubility profile and pHmax. The equations serve as a valuable tool to aid in the calculation of salt solubility at pH below the pHmax in the presence of common counter ions. This provides the knowledge to assess the risks of pre-selection of the salt formers without the necessity of salt synthesis. The solubilities calculated by this model demonstrate good agreement with experimental solubility results reported in the literature. Compared to the conventional approaches for salt solubility and pHmax calculation, our model stands out, especially for poorly water-soluble bases with low pKa values, which benefit the most from salt formation. Moreover, the equations are used to support the concept that salt selection should focus on finding salt forms with sufficient solubility, rather than the most soluble salt, as excessively high solubility could be detrimental to physical stability.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PH-SOLUBILITY PROFILES OF ORGANIC-BASES AND THEIR HYDROCHLORIDE SALTS
    SERAJUDDIN, ATM
    MUFSON, D
    PHARMACEUTICAL RESEARCH, 1985, (02) : 65 - 68
  • [2] METHODS FOR CALCULATING THE PH OF AQUEOUS-SOLUTIONS OF SALTS OF MONOPROTIC ACIDS AND BASES
    MALINOWSKI, ER
    JOURNAL OF CHEMICAL EDUCATION, 1990, 67 (06) : 502 - 504
  • [3] GENERAL TREATMENT OF PH-SOLUBILITY PROFILES OF WEAK ACIDS AND BASES AND THE EFFECTS OF DIFFERENT ACIDS ON THE SOLUBILITY OF A WEAK BASE
    STRENG, WH
    HSI, SK
    HELMS, PE
    TAN, HGH
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (12) : 1679 - 1684
  • [4] Simultaneous enhancements of solubility and dissolution rate of poorly water-soluble febuxostat via salts
    Zhang, Xian-Rui
    Zhang, Lei
    JOURNAL OF MOLECULAR STRUCTURE, 2017, 1137 : 328 - 334
  • [5] Modification of microenvironmental pH of nanoparticles for enhanced solubility and oral bioavailability of poorly water-soluble celecoxib
    Woo, Mi Ran
    Bak, Young-Woo
    Cheon, Seunghyun
    Kim, Jung Suk
    Ji, Sang Hun
    Park, Seonghyeon
    Woo, Sanghyun
    Kim, Jong Oh
    Jin, Sung Giu
    Choi, Han-Gon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 659
  • [6] A review on solubility enhancement methods for poorly water-soluble drugs
    Ainurofiq, Ahmad
    Putro, David Sarono
    Ramadhani, Dhea Aqila
    Putra, Gemala Mahendra
    Santo, Laura Da Costa Do Espirito
    JOURNAL OF REPORTS IN PHARMACEUTICAL SCIENCES, 2021, 10 (01): : 137 - 147
  • [7] Rigorous modeling the pH-dependent solubility of weak acids, weak bases and their salts
    Fritschka, Espen
    Sadowski, Gabriele
    FLUID PHASE EQUILIBRIA, 2024, 580
  • [8] Enhancing the intestinal absorption of poorly water-soluble weak-acidic compound by controlling local pH
    Iwanaga, Kazunori
    Kato, Shino
    Miyazaki, Makoto
    Kakemi, Masawo
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (12) : 1887 - 1894
  • [9] Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
    Kumar, Sandeep
    Dilbaghi, Neeraj
    Saharan, Ruma
    Bhanjana, Gaurav
    BioNanoScience, 2012, 2 (04) : 227 - 250
  • [10] Oral formulation strategies to improve solubility of poorly water-soluble drugs
    Singh, Abhishek
    Worku, Zelalem Ayenew
    Van den Mooter, Guy
    EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (10) : 1361 - 1378